Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,346,864
-$62,348 QoQ
Shares Held
25,222
-14.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
4.04%
of 13F equity value
Holder Rank
#1,170
of 4,153 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Empire Financial Management Company, LLC holds $13,403,297 across 5 Drug Manufacturers - General names. ABBV ranks #1 (47.4% of the industry book) .
All Filings in ABBV
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,346,864 | 25,222 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,409,212 | 29,469 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $6,507,623 | 28,481 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,584,302 | 28,437 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,151,140 | 27,751 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,682,810 | 27,123 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,010,962 | 28,199 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,344,087 | 11,870 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $2,053,094 | 11,970 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,378,590 | 13,062 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,250,607 | 8,070 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $1,197,995 | 8,037 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,990,905 | 14,777 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $2,607,133 | 16,359 | Shares | Sole | 2023-04-20 | |
| No filing history on record for this holder in this stock. | ||||||